“Leukemia patients got a ray of hope last week when the U.S. Food and Drug Administration approved a new drug that targets a subset of leukemia patients with a genetic abnormality that makes the cancer harder to treat,” according to ChicagoTribune.com. For more information, please visit: http://www.chicagotribune.com/business/ct-u-of-c-abbvie-0420-biz-20160419-story.html
The post University of Chicago, AbbVie Sign Cancer Research Deal appeared first on Q1 Productions.
